SOLIDARITY trials
COVID-19 treatment: SOLIDARITY trial is restarting with 3 drugs this time
The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients
WHO mega trial results out: Remdesivir, Interferon fail to prove effective
None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir
- Israeli tourists attack vigil in Cusco in support of Palestine
- During Red April, Brazil’s MST restates the importance of agrarian reform
- German authorities’ crackdown on Palestine Conference sparks widespread outrage
- As elections approach, India’s farmers count government’s broken promises
- Argentine unions call another general strike for May 9
